Allevi
500 Global 2015 · Developer of 3D bioprinters and bioinks intended to cure disease, eliminate the organ waiting list and reverse climate change.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Not stated | 500 GlobalGA 27 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCS21 | |
| AI | Not stated | 500 GlobalMena 2 | |
| AI | Acquired | YCW19 | |
| Other | Not stated | Plug and Play | |
| Other | Not stated | Plug and Play |
Also from 500 Global
All of 500 GlobalPrograms
| Program | Cohort | Source |
|---|---|---|
| 2015 | 500 Global Page |
About Allevi
Developer of 3D bioprinters and bioinks intended to cure disease, eliminate the organ waiting list and reverse climate change. The company's 3D bioprinters and bioinks provide a printer that uses a special ink combined with biomaterials and living cells to build 3D living tissue and miniature human organs to unleash the biological revolution
- Category
- Other
- Location
- United States
- Checked
- 2h ago
Tags: BioTech & Life Sciences
Allevi: questions
Which accelerators did Allevi go through?
Allevi is listed by 500 Global (Global 2015).
Where is Allevi based?
Allevi lists United States as its location on 500 Global's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.